Ironwood Sees Progress For New Drug

Posted in pre-market 
September 14th, 2010

Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) is up 16.98% at 8:35 AM EST this morning to $11.40 on reports that there have been positive late-stage clinical trials for the company’s new drug for treating irritable bowel syndrome and constipation.  The company has already traded 5,234 shares in premarket trading, compared with their daily average of 201,364.  This gain comes during a 52-week range of $8.90 to $15.03.

Ironwood is a biopharma company the creates drugs used for therapeutic needs.  They are based out of Cambridge, MA.

Comments are closed